Market Research Reports- Consulting Analysis Crystal Market Research Synthetic Biology Market | Page 2
Browse full research report with TOC on “Synthetic Biology Market by Product and Application -
Global Industry Analysis and Forecast to 2025” at:
https://www.crystalmarketresearch.com/report/synthetic-biology-market
Reduction in the cost of DNA sequencing, rise in the development of genetically engineered crops,
increased research and development related expenditure of biotechnology and pharmaceutical companies,
growing demand for synthetic genes are set to drive this market. On the other hand, stringent regulations
related to bio-safety & bio-security can restrict the growth of this market.
In 2016, enabled product segment occupied the major share of the global synthetic biology market owing
to growing demand for higher-value specialty products. Besides, core product will grow at highest CAGR
during the forecast period owing to increasing use of synthetic genes and development of DNA
constructs. Healthcare segment occupied the major share of the overall synthetic biology market in 2016
owing to high usage in developing economical drugs and vaccines.
In 2016, Europe occupied the major share of the synthetic biology market owing to rising government
funding and increased R&D efforts. On the other hand, Asia-Pacific is projected to witness significant
growth in the forecast period.
Strategic collaborations is the key strategy adopted by the leading players in the market. For instance, in
May 2017, Oxford Genetics (a leading synthetic biology-based technology company) entered into a non-
exclusive licensing agreement with ERS Genomics. This agreement grants Oxford Genetics to access
ESR’s foundational intellectual property about CRISPR/Cas9 gene editing technology. Similarly, in May
2016, Bayer and ESR Genomics entered into a patent license agreement. As per the terms of agreement,
Bayer obtained access to ESR’s genome editing patent portfolio (i.e. CRISPR-Cas9) for cross divisional
applications in its strategic business areas.
Request a sample copy of Synthetic Biology Market Research Report @
https://www.crystalmarketresearch.com/report-sample/HC06129
Some of the leading players in the global synthetic biology market are New England Biolabs, Inc.,
Synthetic Genomics Inc., Integrated DNA Technologies, Inc.,DuPont,Amyris, Inc., GenScript, Intrexon
Corporation, Gingko Bioworks, Thermo Fisher Scientific Inc., Intrexon Corporation, and Agilent
Technologies, Inc.
Key Findings of the Research Study:
Enabled product segment accounted for the largest share of the overall market in 2016
Core product category is poised to be the fastest-growing segment during the forecast period